Published in J Clin Invest on February 01, 1976
The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev (2007) 6.79
Autoradiographic localization of beta-adrenoceptor subtypes in guinea-pig kidney. Br J Pharmacol (1985) 0.93
Mechanisms of portal hypertension-induced alterations in renal hemodynamics, renal water excretion, and renin secretion. J Clin Invest (1976) 0.89
Mechanisms of renin secretion during hemorrhage in the dog. J Clin Invest (1979) 0.84
Changes in glomerular hemodynamic response to angiotensin II after subacute renal denervation in rats. J Clin Invest (1986) 0.80
Effect of catecholamines and the renal nerves on renin secretion in anesthetized dogs. Am J Physiol (1965) 1.87
Effects of hematocrit on renal hemodynamics and sodium excretion in hydropenic and volume-expanded dogs. J Clin Invest (1970) 1.67
Andrenergic stimulation of renin secretion in the isolated perfused rat kidney. Circ Res (1973) 1.56
THE INNERVATION OF THE JUXTAGLOMERULAR APPARATUS. AN ELECTRON MICROSCOPIC STUDY OF THE INNERVATION OF THE GLOMERULAR ARTERIOLES. Lab Invest (1964) 1.45
Neural stimulation of release of renin. Circ Res (1966) 1.41
Renin release after hemorrhage and after suprarenal aortic constriction in dogs without sodium delivery to the macula densa. Circ Res (1970) 1.29
Adrenergic component of renin release induced by vasodilating antihypertensive drugs in the rat. Circ Res (1973) 1.27
Effect of renal nerve stimulation, renal blood flow and adrenergic blockade on plasma renin activity in the cat. J Physiol (1972) 1.24
The effect of alpha- and beta-adrenergic blocking agents on the renin response to hypoglycemia and epinephrine in dogs. Endocrinology (1970) 1.20
An effect of extrarenal beta adrenergic stimulation on the release of renin. J Clin Invest (1972) 1.10
Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity. J Clin Invest (1975) 1.07
Comparison of the effects on renin release of beta adrenergic antagonists with differing properties. J Clin Invest (1974) 1.05
Effect of alpha- and beta-adrenergic blocking agents on the increase in renin secretion produced by stimulation of the medulla oblongata in dogs. Neuroendocrinology (1971) 1.01
Effect of hypoglycemia on plasma renin activity in dogs. Endocrinology (1970) 1.01
Determination of plasma renin concentration by angiotensin I immunoassay. Diagnotic import of precise measurement of subnormal renin in hyperaldosteronism. Circ Res (1971) 1.00
Effects of catecholamines and renal nerve stimulation on renin release in the nonfiltering kidney. Circ Res (1971) 0.99
Mechanisms of renal release of renin by electrical stimulation of the brainstem in the cat. Circ Res (1974) 0.95
Observations on the mechanism of renin release by catecholamines. Circ Res (1970) 0.95
Sympathetic innervation of the juxtaglomerular cells of the kidney. Circ Res (1968) 0.95
Adrenergic innervation of the canine kidney. Circ Res (1968) 0.94
Selective stimulation of renal nerves in the anesthetized dog. Effect on renin release during controlled changes in renal hemodynamics. Circ Res (1973) 0.94
Effect of stimulation of the medulla oblongata on renin secretion in dogs. Neuroendocrinology (1971) 0.90
Effect of alpha- and beta-adrenergic blocking agents on the increase in renin secretion produced by stimulation of the renal nerves. Neuroendocrinology (1972) 0.89
Increased renin release evoked by mesencephalic stimulation in the dog. Jpn Heart J (1967) 0.83
The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med (1998) 7.18
High throughput fingerprint analysis of large-insert clones. Genome Res (1997) 6.91
Making health care safer: a critical analysis of patient safety practices. Evid Rep Technol Assess (Summ) (2001) 4.60
Development and validation of the Ontario acute myocardial infarction mortality prediction rules. J Am Coll Cardiol (2001) 3.39
The human costs of tobacco use (1) N Engl J Med (1994) 3.24
Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest (2001) 2.84
The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.82
Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med (1985) 2.82
Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care (2000) 2.36
Osmotic and nonosmotic control of vasopressin release. Am J Physiol (1979) 2.18
Urinary diagnostic indices in acute renal failure: a prospective study. Ann Intern Med (1978) 2.13
We're at war--but where are our troops? Hosp Pract (Off Ed) (1994) 2.01
The human costs of tobacco use (2) N Engl J Med (1994) 1.93
Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis (2000) 1.86
Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney. J Clin Invest (1975) 1.85
Overestimation of clinical diagnostic performance caused by low necropsy rates. Qual Saf Health Care (2005) 1.82
Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med (1987) 1.76
Mechanism of the antidiuretic effect associated with interruption of parasympathetic pathways. J Clin Invest (1972) 1.72
The autopsy as an outcome and performance measure. Evid Rep Technol Assess (Summ) (2002) 1.71
Effects of hematocrit on renal hemodynamics and sodium excretion in hydropenic and volume-expanded dogs. J Clin Invest (1970) 1.67
Composition and dynamics of plasma in Saturn's magnetosphere. Science (2005) 1.66
The use of anabolic steroids in high school students. Am J Dis Child (1990) 1.65
Nonoliguric acute renal failure. N Engl J Med (1977) 1.64
Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int (1998) 1.64
Unrecognized adult salicylate intoxication. Ann Intern Med (1976) 1.63
Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1994) 1.61
The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol (2001) 1.58
Mechanism of antidiuretic effect of beta adrenergic stimulation. J Clin Invest (1972) 1.54
Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail (1995) 1.52
Role of vasopressin in the impaired water excretion of glucocorticoid deficiency. Kidney Int (1980) 1.50
Postoperative hyponatremia. A prospective study. Arch Intern Med (1986) 1.50
Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med (1981) 1.49
Making health care safer II: an updated critical analysis of the evidence for patient safety practices. Evid Rep Technol Assess (Full Rep) (2013) 1.49
Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med (1982) 1.48
The effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a pooled analysis of individual-patient data from 11 randomized, controlled trials. Ann Intern Med (2001) 1.44
Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease. Ann Intern Med (1991) 1.44
Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. JAMA (1999) 1.43
Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int (2001) 1.41
Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care (1996) 1.40
Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med (1988) 1.40
Infusion of glycine does not attenuate in vivo ischemic acute renal failure in the rat. J Lab Clin Med (1993) 1.40
Health care reform at $2 a pack. Hosp Pract (Off Ed) (1993) 1.39
Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1997) 1.37
Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med (1998) 1.36
Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int (1990) 1.36
Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am J Kidney Dis (1998) 1.32
Renal tubular acidosis associated with toluene "sniffing". N Engl J Med (1974) 1.32
Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects. J Am Soc Nephrol (2001) 1.29
Polyuria of thyrotoxicosis: downregulation of aquaporin water channels and increased solute excretion. Kidney Int (2007) 1.28
Mechanism of effect of alpha adrenergic stimulation with norepinephrine on renal water excretion. J Clin Invest (1973) 1.28
Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology (1998) 1.27
Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol (1997) 1.26
Upregulation of aquaporin-2 water channel expression in chronic heart failure rat. J Clin Invest (1997) 1.25
Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann Intern Med (1982) 1.24
In vivo effect of indomethacin to potentiate the renal medullary cyclic AMP response to vasopressin. J Clin Invest (1977) 1.24
The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int (1989) 1.24
Loop diuretic infusion increases thiazide-sensitive Na(+)/Cl(-)-cotransporter abundance: role of aldosterone. J Am Soc Nephrol (2001) 1.23
Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci U S A (1994) 1.20
Downregulation of the calpain inhibitor protein calpastatin by caspases during renal ischemia-reperfusion. Am J Physiol Renal Physiol (2000) 1.18
Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med (1997) 1.18
Diagnostic importance of an increased serum anion gap. N Engl J Med (1980) 1.18
Renal, metabolic, and circulatory responses to heat and exercise. Studies in military recruits during summer training, with implications for acute renal failure. Ann Intern Med (1970) 1.18
Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail (1998) 1.17
Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure. Kidney Int (1986) 1.16
Effect of beta-adrenergic blockade and inhibitors of angiotensin II and prostaglandins on renal autoregulation. Am J Physiol (1975) 1.16
Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. J Clin Invest (1988) 1.15
Mechanism of suppression of vasopressin during alpha-adrenergic stimulation with norepinephrine. J Clin Invest (1974) 1.15
Mechanism of increased sodium reabsorption during propranolol administration. Circulation (1971) 1.14
Mechanism of effect of hypoxia on renal water excretion. J Clin Invest (1978) 1.14
Effects of vitamin D-induced chronic hypercalcemia on rat renal cortical plasma membranes and mitochondria. Am J Physiol (1987) 1.14
On the mechanism of polyuria in potassium depletion. The role of polydipsia. J Clin Invest (1977) 1.13
Sodium, potassium and water metabolism in the syndrome of inappropriate antidiuretic hormone secretion. Am J Med (1970) 1.12
Renal cell carcinoma: unusual systemic manifestations. Medicine (Baltimore) (1976) 1.11
Pathogenesis and management of hyponatremia. Am J Med (2000) 1.11
Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology (1995) 1.11
The renal risks of smoking. Kidney Int (1997) 1.10
An effect of extrarenal beta adrenergic stimulation on the release of renin. J Clin Invest (1972) 1.10
Reconstitution of an endosome-lysosome interaction in a cell-free system. J Cell Biol (1989) 1.10
Mechanism of stimulation of vasopressin release during beta adrenergic stimulation with isoproterenol. J Clin Invest (1974) 1.09
Use and accuracy of state death certificates for classification of sudden cardiac deaths in high-risk populations. Am Heart J (1997) 1.08
The global tobacco epidemic. Sci Am (1995) 1.07
The nature of renal cell injury. Kidney Int (1997) 1.06
Mechanism of effect of prostaglandin E 1 on renal water excretion. J Clin Invest (1973) 1.06
Protective effect of intrarenal calcium membrane blockers before or after renal ischemia. Functional, morphological, and mitochondrial studies. J Clin Invest (1984) 1.06
VEGF receptor inhibition slows the progression of polycystic kidney disease. Kidney Int (2007) 1.06
Nephropathy associated with heat stress and exercise. Ann Intern Med (1967) 1.04
Role of caspases in hypoxia-induced necrosis of rat renal proximal tubules. J Am Soc Nephrol (1999) 1.04
Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology (1996) 1.04
Role of cardiac output and the autonomic nervous system in the antinatriuretic response to acute constriction of the thoracic superior vena cava. Circ Res (1971) 1.04
Pathogenic mechanisms in early norepinephrine-induced acute renal failure: functional and histological correlates of protection. Kidney Int (1978) 1.03
Mechanism of effect of thoracic inferior vena cava constriction on renal water excretion. J Clin Invest (1974) 1.03
Factors involved in antinatriuretic effects of acute constriction of the thoracic and abdominal inferior vena cava. Circ Res (1971) 1.03
1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study. Ann Intern Med (1978) 1.02